GlobeNewswire

Cisco Accelerates Multicloud Journey with HyperFlex Platform Innovations

Dela

Adds support for containers and Microsoft Hyper-V, integrates multicloud services 

SAN JOSE, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Cisco today announced platform innovations for Cisco® HyperFlex(TM) with the 3.0 software release that delivers performance and simplicity for any application, on any cloud, at any scale.   Enhancements include support for Microsoft Hyper-V, stretch clusters, containers, and new multicloud services that enable applications to be deployed, monitored and managed in any cloud. The result is a platform that uniquely enables development and deployment of both traditional and cloud-native applications on a common hyperconverged platform.

Cisco HyperFlex: The Power to Simplify More
Other hyperconverged solutions neglect the crucial roles that networking and distributed file systems play in the performance and scaling of clustered servers. Cisco redefined hyperconvergence with a complete end-to-end approach that engineers high performance server and networking technology, with a purpose-built filesystem. The result is industry leading performance that enables customers to efficiently support a broader array of applications, including databases and mission critical ERP workloads. 

"HyperFlex's approach enables high performance of Microsoft SQL and Oracle databases and critical applications with faster delivery of the environment, lower costs, and more effective management," said Edivaldo Rocha, CEO, CorpFlex.

The latest release of HyperFlex builds on this superior architecture and expands the opportunity for customers to simplify more.  "Customers tell us they need operational simplicity, effortless scalability, and the ability to serve the unique needs of each of their applications," said Liz Centoni, senior vice president and general manager of Cisco's Computing Systems Product Group.  "The new HyperFlex platform underscores our commitment to continuously simplify and improve data center operations and help organizations thrive in a multicloud world."

Run Any Application
The HyperFlex 3.0 software release delivers significant advancements for mission critical and cloud-native workloads:

  • Multi-hypervisor Support. In addition to VMware ESXi, HyperFlex adds hypervisor support for Microsoft Hyper-V.
  • Container Support. Data platform enhancements include a FlexVolume driver to enable persistent storage for Kubernetes managed containers, enabling development and deployment of cloud-native applications on HyperFlex.
  • Enterprise Application Validations. HyperFlex is ready for a wide range of workloads with workload profiling and sizing tools available to support application migration projects. In addition to design and deployment guides for Virtual Server Infrastructure (VSI) and Virtual Desktop Infrastructure (VDI) , Cisco design guides are now available for mission critical databases, analytics and ERP applications - including Oracle, SQL, SAP, Microsoft Exchange, and Splunk.

On Any Cloud
Organizations today require workload mobility and application monitoring across public and private clouds.  HyperFlex is the platform for the multicloud era featuring new service integrations with Cisco's multicloud software portfolio:

  • Application Performance Monitoring. AppDynamics with HyperFlex enables performance monitoring of hybrid applications running on HyperFlex and across multiple clouds.
  • Application Placement. Cisco Workload Optimization Manager (CWOM) for HyperFlex assists customers with automated analysis and workload placement.
  • Cloud Management. Introduced last year, CloudCenter for HyperFlex enables workload lifecycle management across one to many private and public clouds.
  • Private Cloud. CloudCenter for HyperFlex simplifies the deployment and management of VM's, containers and applications, making it easy for developers and administrators to consume private clouds.

At Any Scale
Only Cisco enables customers to power rapidly growing workloads with comprehensive resiliency while enjoying the global reach of cloud-based systems management.

  • Greater Scalability and Resiliency On-prem. Supporting customers with higher virtual machine density,  HyperFlex clusters now scale to 64 nodes with added resiliency through fully-automated availability zones. 
  • Stretch Clusters Across Datacenters. To meet data protection and high availability requirements, HyperFlex can now be configured into stretch clusters for campus and metro mission critical availability.
  • Cloud-based Management Across Datacenters.   Cisco Intersight now supports HyperFlex Cloud Deployment, extending simplified deployment and management to any remote location.

Applications are at the heart of digital transformation.  The changing application landscape demands support for both traditional, monolithic workloads as well as distributed microservices architectures. In addition, the ability to enable a multicloud operating environment is quickly becoming a data center requirement. According to IDC's July 2017 CloudView Survey, 85 percent of respondents are evaluating or using public cloud, while among current cloud users 87 percent have taken steps towards a hybrid cloud strategy and 94 percent plan to use multiple clouds.

Organizations are rapidly adopting hyperconverged infrastructure (HCI) to help simplify their environments.  HCI is one of the fastest growing segments in the data center space with a 5-year CAGR (2016-2021) of 30.2 percent (Source: IDC Worldwide Quarterly Converged Systems Forecast Tracker, 3CQ17).  Cisco HyperFlex is being adopted as the platform of choice for enterprise IT, accelerating this market transition with more than 2000 customers globally.

Additional Resources

About Cisco HyperFlex Systems(TM)

Cisco HyperFlex Systems delivers complete hyperconvergence, combining compute, storage, and networking resources into a simplified, easy-to-use platform. The HyperFlex data platform engineered with Cisco Unified Computing System(TM) (Cisco UCS®) delivers a dynamic data fabric(TM) with the industry-leading performance customers need to simplify more applications in their data centers. Cisco HyperFlex Systems deliver the agility, scalability, and pay-as-you-grow economics of the cloud, but with the benefits of on-premises infrastructure. Cisco HyperFlex. Simplify more. 

About Cisco
Cisco (NASDAQ:CSCO) is the worldwide technology leader that has been making the Internet work since 1984. Our people, products, and partners help society securely connect and seize tomorrow's digital opportunity today. Discover more at thenetwork.cisco.com and follow us on Twitter at @Cisco.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco's trademarks can be found at www.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company.

Press Relations                                                                       
Lee Davis                                                                                               
Cisco                                                                                                           
650-868-3036                                                                                                                     
leedavis@cisco.com                                                               

Analyst Relations
Jennie Olean 
Cisco
978 936-0223
jolean@cisco.com 

Investor Relations
Carol Villazon
Cisco
408-527-6538
carolv@cisco.com

Photos accompanying this announcement are available at 
http://www.globenewswire.com/NewsRoom/AttachmentNg/f62645a1-5b28-4671-ac70-24a5338e2371 http://www.globenewswire.com/NewsRoom/AttachmentNg/312438df-ca48-4c77-ac19-4664ff6f1106




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cisco via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Arcoma presenterar på Redeye Life Science Day den 21:a november16.11.2018 12:53Pressmeddelande

16 November Den 21 november presenterar Jesper Söderqvist, VD på Arcoma, den senaste utvecklingen i Arcoma på Haymarket by Scandic i Stockholm. Presentationen "Arcoma, ett tillväxtbolag i en växande marknad" hålls klockan 13:00 och kan följas i livesändning på redeye.se/live/lsday-2018. Presentationen kommer även i efterhand att finnas tillgänglig på www.redeye.se/live/ls-day-2018 samt på Bolagets sida i Redeye Universe (redeye.se/company/Arcoma) Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem installerade

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum